Orexigen Therapeutics, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/17 Q3

ended 06/30/17 Q2 2017 – amended

ended 06/30/17 Q2

ended 03/31/17 Q1

ended 12/31/16 FY 2016 – amended

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Prospectus supplement for primary offering

Exempt offering of securities

Registration of securities for employees

Ownership Filter

Klarman Seth A, Baupost Group LLC/Ma, Baupost Group GP, L.L.C.

Baupost Group LLC/Ma

Telemetry Investments, L.L.C.

Biotechnology Value Fund L P

OCONNOR, a Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)

News Filter

Bankruptcy or Receivership, Financial Statements or Exhibits

Case 18-10518-Kg Doc 1081 Filed 04/29/19 Page 1 of 11

Case 18-10518-Kg Doc 1006 Filed 03/29/19 Page 1 of 11

Case 18-10518-Kg Doc 958 Filed 02/28/19 Page 1 of 11

Monthly Operating Report

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Confidential treatment order

Confidential treatment order

Confidential treatment order

Confidential treatment order

Confidential treatment order